Skip to content

Clinical trials

Phase 2 Gallbladder Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gallbladder Neoplasms Phase: Phase 2 Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20027
20034
20043
20052
20063
20072
20083
20093
20104
20112
20121
20132
20144
20153
20164
20175
20183
20193
20208
20213
20223
20234
20247
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Unknown status14
Terminated12
Active, not recruiting9
Recruiting8
Withdrawn4
Not yet recruiting3
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)19
Shanghai Jiao Tong University School of Medicine4
Alliance for Clinical Trials in Oncology3
M.D. Anderson Cancer Center3
Tianjin Medical University Cancer Institute and Hospital3
Asan Medical Center2
Case Comprehensive Cancer Center2
Eastern Hepatobiliary Surgery Hospital2
H. Lee Moffitt Cancer Center and Research Institute2
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gallbladder Neoplasms100
Cholangiocarcinoma48
Bile Duct Neoplasms40
Biliary Tract Neoplasms23
Carcinoma, Hepatocellular22
Liver Neoplasms12
Pancreatic Neoplasms9
Colorectal Neoplasms7
Esophageal Neoplasms7
Neoplasm Metastasis7

Trials

Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.